Home Newsfeeds UBS Maintains Neutral on VMware, Raises Price Target to $147

UBS Maintains Neutral on VMware, Raises Price Target to $147

UBS analyst Karl Keirstead maintains VMware (NYSE:VMW) with a Neutral and raises the price target from $131 to $147.

byBenzinga Newsdesk

February 7, 2023

1 minute read

UBS analyst Karl Keirstead maintains VMware (NYSE:VMW) with a Neutral and raises the price target from $131 to $147.

What’s Going On With Robinhood Markets Stock Today?

By Adam Eckert

May 11, 9:15 AM

Robinhood Markets Inc (NASDAQ: HOOD) shares are rising Thursday after the company reported strong first-quarter results and announced 24-hou

HOOD

Barclays Maintains Overweight on Navient, Lowers Price Target to $18

By Benzinga Newsdesk

July 11, 8:32 AM

Barclays analyst Mark Devries maintains Navient (NASDAQ:NAVI) with a Overweight and lowers the price target from $25 to $18.

NAVI

Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate

By Vandana Singh

October 6, 8:03 AM

Provention Bio Inc (NASDAQ:PRVB) has entered into a co-promotion agreement with Sanofi SA (NASDAQ:SNY) to launch Provention’s lead investigational candidate, teplizumab, to delay…

PRVB

Aerospace Company Barnes Strikes $175M Deal To Divest Associated Spring & Hänggi, Aiming To Slash Debt

By Shivani Kumaresan

January 11, 12:41 PM

Industrial manufacturer Barnes Group Inc (NYSE: B) has entered into a definitive agreement to sell its Associated Spring and Hänggi businesses

UBS Maintains Neutral on VMware, Raises Price Target to $147

Related Posts

What’s Going On With Robinhood Markets Stock Today?

Barclays Maintains Overweight on Navient, Lowers Price Target to $18

Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate

Aerospace Company Barnes Strikes $175M Deal To Divest Associated Spring & Hänggi, Aiming To Slash Debt